Genotypying of clinical isolates of Helicobacter pylori by cagA, vacA and babA2 virulence associated genes. First detection of a babA2 positive strain in Chilean patients;Genotipificación de aislados clínicos de Helicobacter pylori en base a genes asociados a virulencia cagA, vacA y babA2. Primer aislamiento de una cepa babA2 positiva en pacientes chilenos

Revista Medica de Chile

Volumn 134, Issue 8, 2006, Pages 981-988

  García C, Apolinaria ^a,b   Barra T, Ricardo ^a   Delgado Sch, Carolina ^b   Kawaguchi P, Fernando ^b   Trabal F, Natalia ^a   Montenegro H, Sonia ^c   González C, Carlos ^a  

^a Facultad de Ciencias Biologicas   (Chile)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

^c OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

babA protein, Helicobacter pylori; cagA protein, Helicobacter pylori; Helicobacter pylori; vacA protein, Helicobacter pylori

Indexed keywords

ADHESIN; BABA PROTEIN, HELICOBACTER PYLORI; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; VACA PROTEIN, HELICOBACTER PYLORI;

ARTICLE; BIOPSY; CHILE; GASTROINTESTINAL DISEASE; GENETIC MARKER; GENETICS; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PEPTIC ULCER; POLYMERASE CHAIN REACTION; VIRULENCE;

ADHESINS, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOPSY; CHILE; GASTROINTESTINAL DISEASES; GENETIC MARKERS; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; POLYMERASE CHAIN REACTION; VIRULENCE;

EID: 33751292628     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Taylor D, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991; 13: 42-59.
2. Nilsson C, Sillen A, Eriksson L, Strand ML, Enroth H, Normark S et al. Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal diseases. Infec Immun 2003; 71: 6573-81.
3. Marshall B. Helicobacter pylori. Am J Gastroenterol 1994; 89: 116-27.
4. Foreman D, The Eurogast Study Group. An International Association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 359-62.
5. Wotherspoon A, Doglioni C, Diss T, Pan L, Moschini A, De Boni M et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
6. Azuma T, Ito S, Sato F, Yamazaki Y, Miyaji H, Ito Y et al. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adeno carcinoma induced by Helicobacter pylori infection. Cancer 1998; 82: 1013-8.
7. Kato I, Vivas J, Plummer M, López G, Peraza S, Castro D et al. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev 2004; 13: 468-76.
8. Yang J, Wang T, Wang H, Kuo C, Wang J, Wang W. Genetic analysis of the cytotoxin associated gene and the vacuolating gene in Helicobacter pylori strains isolated from Taiwanese patients. Am J Gastroenterol 1997; 92: 1316-21.
9. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004; 113: 321-33.
10. Covacci A, Censini S, Bugnoli M. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5.
11. Censini S, Lange C, Xiang Z, Crabtree J, Ghiara P, Borodovskym et al. Cag, a pathogenicity island of Helicobacter pylori, encoded type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-53.
12. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999; 284: 1328-33.
13. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 1771-7.
14. Van Doorn LJ, Figueiredo C, Sanna R, Pena AS, Midolo P, Atherton JC et al. Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 1998; 36: 2597-603.
15. Mizushima T, Sugiyama T, Komatsu Y, Ishizuka J, Kato M, Asaka M. Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J Clin Microbiol 2001; 39: 2463-5.
16. Lai C-H, Kuo C-H, Chen Y-C, Chao F-Y, Poon S-K, Chang C-S et al. High prevalence of cagA and babA2 positive Helicobacter pylori clinical isolates in Taiwan. J Chin Med Assoc 2002; 40: 3860-2.
17. Yu J, Leung WK, Go MYY, Cjhan MCW, To KF, Ng EKW et al. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 2002; 51: 480-4.
18. Boren T, Normark S, Falk P. Helicobacter pylori: molecular basis for host recognition and bacterial adherence. Trends Microbiol 1994; 2: 221-8.
19. Gerhard M, Lehn N, Neumayer N, Borer T, Rod R, Schepp W et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1996; 96: 12778-83.
20. Alves OA, Santos A, Becattini GJ, Aguiar RG, Camargos RA, Oliveira C et al. babA2-and cagA-Positive Helicobacter pylori Strains Are Associated with Duodenal Ulcer and Gastric Carcinoma in Brazil. J Clin Microbiol 2003; 41: 3964-6.
21. Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and s1vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 2003; 56: 287-91.
22. Prado V. Enfermedades infecciosas emergentes: ¿Un problema nuevo? Rev Méd Chile 1996; 124: 7-10.
23. Martínez A, González C, Kawaguchi F, Montoya R, Corvalán A, Madariaga J et al. Helicobacter pylori: análisis de cagA y genotipificación de vacA en Chile. Detección de una cepa s2/m1. Rev Méd Chile 2001; 129: 1147-53.
24. Faúndez G, Troncoso M, Figueroa G. cagA and vacA in strains of Helicobacter pylori from ulcer and non-ulcerative dyspepsia patients. BMC Gastroenterol 2002; 2: 20.
25. Araya J, Anabalón L, Roa I, Bravo M, Villaseca M, Guzmán P et al. Relación de la genotipificación de Helicobacter pylori con la forma e intensidad de la gastritis en población adulta portadora de patología gástrica benigna. Rev Méd Chile 2004; 132: 1345-54.
26. Working Party of the European Helicobacter Pylori Study Group. Guidelines for clinical trials in Helicobacter pylori infection. Gut 1997; 41 (Suppl 2): S3.
27. Mazurier S, Van De Giessen A, Heuvelman K, Wernars K. RAPD analysis of Campylobacter isolates: DNA fingerprinting without the need to purify DNA. Lett Appl Microbiol 1992; 14: 260-2.
28. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993; 61: 1799-809.
29. Salgado F, García A, Oñate A, González C, Kawaguchi F. Increased in-vitro and in-vivo biological activity of lipopolysaccharide extracted from clinical low virulence vacA genotype Helicobacter pylori strains. J Med Microbiol 2002; 51: 771-6.
30. Navaglia F, Basso B, Plebani M. Touchdown PCR: a rapid method to genotype Helicobacter pylori infection. Clin Chim Acta 1997; 262: 57-60.
31. Podzorski R, Podzorski D, Wuerth A, Tolia V. Analysis of the vacA, cagA, cagE, iceA and babA2 genes in Helicobacter pylori from sixty-one pediatric patient from the Midwestern united states. Diagnos Microbiol Infec Dis 2003, 46: 83-8.
32. Hehenberger P, Gretechel S. Gastric Cancer. The Lancet, 2003. Tomo 362, N 9380: pp 305.
33. Kim S-Y, Woo C, Lee Y-M, Son B, Kim J, Chae H et al. Genotyping cagA, vacA subtype, iceA and babA of Helicobacter pylori isolates from Korean patients, and their association with gastroduodenal diseases. J Korean Med Sci 2001; 16: 579-84.
34. Yakoob J, Fan XG, Peng XN, Hu GL, Zhang Z. Helicobacter pylori cagA and vacA cytotoxin genes in Changsha, China. Br J Biomed Sci 2002; 59: 150-3.
35. Xiang Z, Censini S, Bayeli P, Telford J, Figura N, Rappuoli R et al. Analysis of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94-8.
36. Fantry G, Zheng Q, Darwin P, Rosentein A, James S. Mixed infection with cagA-positive and cagA-negative strains of Helicobacter pylori. Helicobacter 1996; 1: 98-106.
37. Weel J, Van Der Hulst R, Gerrits Y, Roorda P, Feller M et al. The Inter relationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori related diseases. J Infect Dis 1996; 173: 1171-5.
38. Lu H, Yamaoka Y, Graham D. Helicobacter pylori virulence factors: facts and fantasies. Current Op Gastroenterol 2005; 21: 653-9.
39. Voland P, Hafsi N, Zeitner M, Laforsch S, Wagner H, Prinz C. Antigenic properties of HpaA and Omp 18, two outer membrane proteins of Helicobacter pylori. Infect Immun 2003; 71: 3837-43.
40. Díaz MI, Lienlaf M, Valdivia A Harris P, Venegas A. Análisis de sueros de pacientes chilenos infectados con Helicobacter pylori indican que HpaA, CagA y VacA son los antígenos más frecuentemente reconocidos. Acta Microbiol 2004; 10: 125.